Research

Generic drug investigation files

Held by the New York State Archives


Overview of the Records

Repository:

New York State Archives

New York State Education Department

Cultural Education Center

Albany, NY 12230

Summary:
The series relates to the law allowing less expensive generic drug to be substituted for a brand name drug. The investigation files include correspondence, memoranda, hearing testimony, conference proceedings, clippings, lists of drug prices, copies of legislation from other States, sample drug company advertising, and various reports on the drug industry and on the safety and effectiveness of generic drugs. Evidence was provided by physicians; pharmacists; pharmaceutical laboratories and manufacturers; medical organizations; government officials; and consumer groups.
Creator:
Title:
Quantity:
13 cu. ft.
Inclusive Dates:
1963-1979
Bulk Dates:
bulk 1977
Series Number:
L0136

Arrangement

Arranged by subject in no apparent order.

Administrative History

A New York State law took effect on April 1, 1978 allowing a consumer, with the consent of a physician, to substitute a less expensive generic drug for a brand name drug originally prescribed.

This drug substitution law (Laws of 1977, Chapter 776) came about after years of complaints by consumers about the high cost of brand name drugs and the desire to have the advantages of lower priced generic substitutions. The law was passed over the opposition of a highly organized pharmaceutical industry lobby. It is credited with saving millions of dollars for New Yorkers since 1978.

Scope and Content Note

This series contains important documentation either gathered by or produced by the Assembly Office of Legislative Oversight and Analysis in its investigative work for the drug substitution law. This Office gathered a tremendous amount of information on the drug industry, assisted Assembly committees with hearings, conducted surveys of drug pricing and drug company sales methods, compiled reports, and performed a wide variety of other tasks to assist the Assembly in preparing the legislation. The majority of the records are from 1977, when hearings were being conducted to determine if a generic drug law was necessary.

The series includes correspondence, memoranda, hearing testimony, conference proceedings, newspaper and journal article clippings, lists of drug prices, copies of legislation from other states, examples of drug company advertising, and various reports on the drug industry and on the safety and effectiveness of generic drugs. The evidence in the records was provided by an extremely broad range of individuals and groups involved in the manufacture, sale, and use of drugs. These include: physicians; pharmacists; pharmaceutical manufactures; medical organizations; local, state, and federal government officials; consumer groups; medical school faculty; and pharmaceutical laboratories.

Use of Records

Access Restrictions

There are no restrictions regarding access to or use of the material.

Related Information

Other finding aids

Folder list.

Access Terms

Geographic Name(s):
Subject(s):
Genre(s):
Function(s):